Clene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Clene Inc. (CLNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 858 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-14
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 0.00 shares.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 858.00 shares.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 50.31K shares.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 611.00 shares.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 54.90K shares, a 11.12% decline from fiscal 2024.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 61.77K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 858.00 shares 10-Q · filed 2026-08-14 | 51.16K shares derived: sum of 3 quarters · filed 2026-08-14 | 51.78K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 858.00 shares 10-Q · filed 2026-05-14 | 51.16K shares derived: sum of 2 quarters · filed 2026-05-14 | 51.78K shares derived: sum of 3 quarters · filed 2026-05-14 | |
| 2025-12-31 | 50.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 50.92K shares derived: sum of 2 quarters · filed 2026-03-17 | 54.90K shares 10-K · filed 2026-03-17 | |
| 2025-09-30 | 611.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 4.59K shares 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | 3.98K shares 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 61.77K shares 10-K · filed 2025-03-24 | ||
| 2024-09-30 | 61.77K shares 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |